This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Danaher offers up five businesses for EU review of $21 billion GE BioPharma deal

By Natalie McNelis ( December 2, 2019, 11:21 GMT | Insight) -- Danaher has offered to divest five businesses in a bid to obtain EU approval for its $21.4 billion acquisition of GE Healthcare Life Science's BioPharma business, MLex has learned. Late on Friday evening, the European Commission sent out sets of questions to customers and competitors asking for their views on whether the commitments Danaher has offered — and its choice of purchaser — would allay their concerns about the deal. They have until Dec. 4 to answer.Danaher has offered to divest five businesses in a bid to obtain EU approval for its $21.4 billion acquisition of GE Healthcare Life Science's BioPharma business, MLex has learned....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login